Clin2
NCT04839757Possibly a fitRecruiting

Testing a dengue vaccine plan for kids in the Caribbean

DengueVaccinationSeroprevalenceInfectious Disease

Part of Infections clinical trials.

This trial looks at a dengue vaccine strategy in children ages 9 to 17 in Martinique and Guadeloupe. It may help protect kids from dengue, based on how the vaccine is accepted and how the study is carried out.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
590 people
Ages
9 years to 17 years
Study type
Observational

Who can take part

  • Be between 9 and 17 years old
  • Live in Martinique or Guadeloupe for at least 1 year
  • You (and a parent/guardian) will be asked to give consent for the study
  • You will need a blood test or a small vein access line as part of care
  • There should be no fever or suspected serious infection when you join

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06891950Recruiting· Phase 3
Dengue vaccine study for healthy older adults

This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.

Curitiba, Paraná
NCT06908018Not yet recruiting· Early Phase 1
Dengue infection study for immune Thai adults

This study tests a controlled dengue infection in people who already have immunity to some types of dengue. It aims to understand how the immune system responds and to help develop better vaccines. You may qualify if you are a healthy adult aged 18-40 and have evidence of prior dengue exposure to certain virus types.

NCT07412483Recruiting
Dengue infection study in healthy adults

This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.

Singapore
NCT06006559Recruiting· Phase 2
Testing a new dengue treatment (EYU688) in adults

This trial tests a new experimental drug, EYU688, for adults with dengue fever. It aims to see if the drug is safe and effective. You may qualify if you have early dengue symptoms, have tested positive for dengue, and are otherwise healthy.

Manaus, Amazonas
NCT06551844Recruiting· Phase 2
Adaptive platform trial for new dengue treatments

This trial tests different experimental drugs to treat dengue early. It aims to find which treatment works best and is safe for patients who start within 48 hours of fever.

Kuala Lumpur
NCT07002021Not yet recruiting
Testing a mosquito-free school program to prevent dengue

This trial is testing whether a "Mosquito-Free Campus" program can help prevent dengue fever in schools. The program will be set up in primary and middle schools in certain areas of Guangzhou and Foshan cities. If your school is in one of these areas and is willing to take part, this study could show how to keep students safe from dengue.

Hear when a new Dengue trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.